Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-044630

President, R&D sold 11,043 shares at $2.06 ($22,749)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Amado Rafael President, R&D 2019-08-06 Sale −11,043 $2.06 $22,749 17,237 D
Open-market sales · 11,043 sh · avg $2.06 · $22,749
Loading xslF345X03/a4.xml…